Bayer Diabetes Care, Nick Jonas encourage consumers to ‘Give Back’
TARRYTOWN, N.Y. Bayer Diabetes Care on Tuesday announced its sponsorship of the contest “Give Back. Simply Win.” — a program that’s expected to shine a spotlight on people with diabetes who are making a difference in their local communities.
Three grand prize winners will meet singer Nick Jonas and Bayer will donate $5,000 to three not-for-profit charitable causes, one selected by each winner.
Bayer’s “Give Back. Simply Win.” contest was designed to reward people with diabetes for their charitable efforts. It is open to people with diabetes in three age categories: 6 to 12, 13 to 17 and 18-plus years.
Entries will be accepted through Aug. 5.
Nick Jonas, now 17, was diagnosed with Type 1 diabetes when he was 13. Since he publicly announced his diagnosis, he has become widely recognized not only for his musical talents, but also for his efforts to inspire people with diabetes and give back to fans that inspire him.
“One of the things we’ve been so impressed with is how much people with diabetes are doing for their communities,” Jonas said. “Bayer and I hope that through this contest we can call attention to them and thank people with diabetes who support and inspire others, whether it be through volunteering or fundraising.”
Novo Nordisk launches online contest for insulin pen users
PRINCETON, N.J. Novo Nordisk is asking diabetics to show off how they flex — their insulin pens.
In an effort to change the way people think about taking insulin, Novo Nordisk has launched an online photo contest, “Where Have You Flexed,” for patients who use Levemir FlexPen, NovoLog FlexPen and NovoLog Mix 70/30 FlexPen. Patients can visit WhereHaveYouFlexed.com to submit photos they have taken in unique locations with their FlexPen.
“’Where Have You Flexed’ is an exciting way for people using the FlexPen to show first-hand how they can conveniently take their insulin on-the-go,” said Camille Lee, VP diabetes marketing for Novo Nordisk. “Through the interactive voting function on the site, we look forward to seeing which entries have the biggest impact within the diabetes community and hope that people still taking insulin with a vial and syringe will be inspired to talk to their doctor about FlexPen.”
Also on the WhereHaveYouFlexed.com site, viewers can watch video with stories from Firestone Indy Lights racecar driver Charlie Kimball, who uses the Levemir FlexPen to help manage his diabetes. The grand prize winner of the Where Have You Flexed contest (determined by a panel of judges and consumer votes) will receive a trip for two to the Firestone Indy Lights championship in Miami on Oct. 2 to see Kimball race, or an elliptical trainer exercise machine delivered to their home. Second and third place winners will receive exercise equipment for their home, while anyone who registers to vote on the site will be entered in a random drawing to win one of five iPod touch portable music players.
“As a professional racing driver, I get to ‘flex’ all over the country — including on the racetrack,” said Kimball, who drives the No. 26 Levemir FlexPen car and is the only licensed racer with Type 1 diabetes in the history of the Indy Racing League. “I’m looking forward to seeing the photos of where other patients with diabetes use their FlexPen and sharing videos of my experiences on the road.”
McNeil Consumer Healthcare recalls lots of infants’, children’s OTC medicines
FORT WASHINGTON, Pa. McNeil Consumer Healthcare on Friday voluntarily recalled all lots that have not yet expired of certain over-the-counter children’s and infants’ liquid products in consultation with the Food and Drug Administration.
McNeil Consumer initiated the recall because some of these products may not meet required quality standards, though no adverse medical events have been reported, the company stated. “However, as a precautionary measure, parents and caregivers should not administer these products to their children.”
Some of the products included in the recall may contain a higher concentration of active ingredient than is specified; others may contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles.
“While the potential for serious medical events is remote, the company advises consumers who have purchased these recalled products to discontinue use,” McNeil stated.
The company is conducting a comprehensive quality assessment across its manufacturing operations and has identified corrective actions that will be implemented before new manufacturing is initiated at the plant where the recalled products were made.
For a full list of products recalled, visit http://www.mcneilproductrecall.com/page.jhtml?id=/include/new_recall.inc